IRCT20220507054758N1尚未招募3 期
Evaluation safety and efficiency of early administration of Tranexamic acid in trauma patient
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 no limit（—）
- 性别
- All
入选标准
- •All patients admitted with multiple trauma over than 15 years old with ABC trauma score more than 2 scores
- •patient satisfaction to study
排除标准
- •brain injuries
- •coaglopathy
- •renal failure
- •using anticoaglants
研究者
相似试验
招募中
3 期
euroEPO in mild-moderate Alzheimer's diseasemild-moderate Alzheimer's diseaseAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementiaRPCEC00000409Center of Molecular Immunology (CIM)413
招募中
不适用
Examination of efficacy and safety of administration of vitamin D3 with the PEG-IFN alpha 2a/Ribavirin therapy to hepatitis C patients with osteoporosis.hepatitis CJPRN-UMIN000004628Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine20
招募中
不适用
A phase I study assessing the safety and performance of VB5-845D-800CW, an fluorescent agent, for the intraoperative detection of gastrointestinal cancerNL-OMON27469eiden University Medical Center (LUMC)34
尚未招募
4 期
Evaluation of effectiveness and safety of first line drugs used in the treatment ofperipheral neuropathy for older individualsCTRI/2021/02/030935ALL INDIA INSTITUTE OF MEDICAL SCIENCES RAIPUR
尚未招募
2 期
Preliminary evaluation of the efficacy and safety of Xuezhikang tablets (LY02404) in the treatment of hyperlipidemia: a multicenter, randomized, double-blind, double-simulation, parallel control of positive drugs, and dose-exploration phase II clinical trialITMCTR2000003402Peking University First Hospital